Showing results (51-60 of 270) with videos related to
Sort By:
Pageof 27
Recenti Progressi in Medicina|April 20, 2016
[Immunotherapy in non-small cell lung cancer: evolution of knowledge and clinical advances]Alessia Pochesci, Antonio Passaro, Chiara Catania, et al.Journal of Thoracic Disease|April 15, 2016
Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?Antonio Passaro, Alessia Pochesci, Gianluca Spitaleri, et al.ESMO Open|March 6, 2020
European Society for Medical Oncology (ESMO) 2018 Congress Twitter analysis: from ethics to results through the understanding of communication and interaction flowsAntonio Passaro, Graham Mackenzie, Matteo Lambertini, et al.Expert Review of Clinical Pharmacology|September 15, 2016
Afatinib for the first-line treatment of patients with metastatic EGFR-positive NSCLC: a look at the dataAntonio Passaro, Alessia Pochesci, Gianluca Spitaleri, et al.Translational Lung Cancer Research|June 15, 2026
Lung cancer with EGFR PACC mutations: a practical review of available treatment options and novel therapies on the horizonJulia M Berg, Hollis Viray, Jenna Green, et al.Cancers|October 14, 2022
Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-AnalysisJianchao Xue, Bowen Li, Yadong Wang, et al.JTO Clinical and Research Reports|February 16, 2024
Targeting MET in NSCLC: An Ever-Expanding TerritoryYing Han, Yinghui Yu, Da Miao, et al.Journal of Thoracic Disease|June 13, 2017
Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspirationAlessandro Tuzi, Elena Bolzacchini, Matteo B Suter, et al.Cancers|October 28, 2023
New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and LimitationsIlaria Attili, Carla Corvaja, Gianluca Spitaleri, et al.Cancer Treatment Reviews|July 23, 2023
Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic reviewIlaria Attili, Antonio Passaro, Carla Corvaja, et al.Pageof 27